Preclinical safety studies of medicines in the Eurasian economic union
This article analyzes the regulatory, scientific, and methodological documents of the Eurasian Economic Union (EAEU) and the Russian Federation devoted to conducting preclinical studies on the safety of medicines. Areas for which it is advisable to develop special EAEU guidelines for conducting prec...
Saved in:
| Main Authors: | G. N. Engalycheva, R. D. Syubaev, A. D. Durnev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC “Publisher OKI”
2025-05-01
|
| Series: | Фармакокинетика и Фармакодинамика |
| Subjects: | |
| Online Access: | https://www.pharmacokinetica.ru/jour/article/view/445 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preclinical Evaluation of the Oral Toxicity, Genotoxicity, and Safety Pharmacology of LPM4870108, a Novel Potent Tropomyosin Receptor Kinase Inhibitor
by: Xiaochen Zhang, et al.
Published: (2025-08-01) -
WoE Analysis and Key Risk Factors in Preclinical Development of Medicinal Products: A Review
by: G. N. Engalycheva, et al.
Published: (2024-12-01) -
Study of the Safety and Toxicokinetic Parameters of the Drug Eladis® in Preclinical Trials with Repeated Administration
by: A. A. Matichin, et al.
Published: (2025-04-01) -
High Dose Selection for General Toxicity Studies of New Medicines
by: G. N. Engalycheva, et al.
Published: (2023-06-01) -
Preclinical Evaluation of a New Anti-COVID-19 Intravenous Immunoglobulin
by: A. M. Nikolaeva, et al.
Published: (2023-02-01)